- Home
- BIO vs AD Comparison
BIO vs AD Comparison
Compare BIO & AD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- AD
- Stock Information
- Founded
- BIO 1952
- AD 1983
- Country
- BIO United States
- AD United States
- Employees
- BIO N/A
- AD N/A
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- AD Telecommunications Equipment
- Sector
- BIO Industrials
- AD Telecommunications
- Exchange
- BIO Nasdaq
- AD Nasdaq
- Market Cap
- BIO 7.7B
- AD 6.4B
- IPO Year
- BIO N/A
- AD N/A
- Fundamental
- Price
- BIO $282.38
- AD $50.00
- Analyst Decision
- BIO Strong Buy
- AD
- Analyst Count
- BIO 4
- AD 0
- Target Price
- BIO $333.50
- AD N/A
- AVG Volume (30 Days)
- BIO 229.1K
- AD 283.0K
- Earning Date
- BIO 10-29-2025
- AD 10-31-2025
- Dividend Yield
- BIO N/A
- AD 45.96%
- EPS Growth
- BIO N/A
- AD N/A
- EPS
- BIO 11.49
- AD N/A
- Revenue
- BIO $2,554,200,000.00
- AD $3,700,000,000.00
- Revenue This Year
- BIO $2.12
- AD $0.37
- Revenue Next Year
- BIO $2.90
- AD N/A
- P/E Ratio
- BIO $24.57
- AD N/A
- Revenue Growth
- BIO N/A
- AD N/A
- 52 Week Low
- BIO $211.43
- AD $49.46
- 52 Week High
- BIO $387.99
- AD $79.17
- Technical
- Relative Strength Index (RSI)
- BIO 51.63
- AD N/A
- Support Level
- BIO N/A
- AD N/A
- Resistance Level
- BIO $298.00
- AD N/A
- Average True Range (ATR)
- BIO 7.29
- AD 0.00
- MACD
- BIO -12.88
- AD 0.00
- Stochastic Oscillator
- BIO 93.86
- AD 0.00
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.